acetazolamide in combination with radioimmunotherapy in patients with extensive SCLC clinical trials

Phase I Trial of CArbonic Anhydrase Inhibition in Combination With Radiochemotherapy or Radioimmunotherapy in Small Cell Lung Carcinoma

This study is looking into a new use for an existing medicine called acetazolamide, in combination with standard treatments for small cell lung cancer. Researchers want to see if it can help improve how well chemotherapy and radiotherapy work by affecting how cancer cells get their energy.